InsidersTradesSigma
Total declarations
Company
▲ Purchases (0 ops.)
▼ Sales (0 ops.)
Explore the full record of transactions filed by Krasner Alan Seth, Directeur Médical. Officer active across 1 company, notably Crinetics Pharmaceuticals, Inc.. Aggregated, 3 disclosures have been logged. Activity tracked since 19 January 2022. The latest transaction was filed on 28 February 2022 (Attribution). Regulator: SEC (Form 4). All data is free.
Declarations3 total
14,250 shares0Common StockSEC:0001209191-22-015129:0
6,700 shares@ US$12.010.0016% mcap50.0% of flowCommon StockSEC:0001209191-22-004453:0
6,700 shares@ US$12.010.0016% mcap100.0% of flowCommon StockSEC:0001209191-22-004453
3 of 3 declarations
About Krasner Alan Seth
Alan Seth Krasner is the Chief Medical Officer at Crinetics Pharmaceuticals, Inc. He is responsible for medical leadership and product development strategies. His role is essential in ensuring that Crinetics' products meet safety and efficacy standards.
